These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3006433)

  • 1. [3H]muscimol and [3H]quinuclidinyl benzilate binding in rat cortex in the abstinence after long-term barbital treatment.
    Nordberg A; Wahlström G; Eriksson B
    Acta Physiol Scand; 1986 Jan; 126(1):153-6. PubMed ID: 3006433
    [No Abstract]   [Full Text] [Related]  

  • 2. Atropine modulates changes in striatal muscarinic receptor binding sites in barbital abstinence in the rat.
    Nordberg A; Wahlström G
    Acta Physiol Scand; 1982 Jul; 115(3):369-71. PubMed ID: 6891170
    [No Abstract]   [Full Text] [Related]  

  • 3. Relations between muscimol, quinuclidinyl benzilate and nicotine binding sites in brain after very long treatment with ethanol in rats.
    Nordberg A; Wahlström G; Eriksson B
    Eur J Pharmacol; 1985 Sep; 115(2-3):301-4. PubMed ID: 4065210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in populations of cholinergic binding sites in brain after chronic exposure to barbital in rats.
    Nordberg A; Wahlström G
    Brain Res; 1982 Aug; 246(1):105-12. PubMed ID: 7127080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ; Morgan WW
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased number of muscarinic binding sites in brain following chronic barbiturate treatment to rat.
    Nordberg A; Wahlström G; Larsson C
    Life Sci; 1980 Jan; 26(3):231-7. PubMed ID: 7189007
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effect of chronic ethanol treatment on barbiturate and steroid modulation of muscimol-binding to rat brain cortex.
    Negro M; Casanova E; Chinchetru MA; Fernández-López A; Calvo P
    Neurosci Lett; 1993 Aug; 158(1):83-6. PubMed ID: 8233077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the methylxanthine derivative pentoxifylline on benzodiazepine and muscarinic binding sites in rat cerebral cortex.
    Lowenstein PR; Aguilar JS; Sabato UC
    Acta Physiol Pharmacol Latinoam; 1985; 35(4):431-9. PubMed ID: 3012947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic localization of GABAergic and muscarinic cholinergic receptor sites in the visual system of the kitten.
    Skangiel-Kramska J; Cymerman U; Kossut M
    Acta Neurobiol Exp (Wars); 1986; 46(2-3):119-30. PubMed ID: 3022561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of muscarinic and nicotinic binding sites in brain.
    Nordberg A; Larsson C
    Acta Physiol Scand Suppl; 1980; 479():19-23. PubMed ID: 6932800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laudanosine does not displace receptor-specific ligands from the benzodiazepinergic or muscarinic receptors.
    Katz Y; Gavish M
    Anesthesiology; 1989 Jan; 70(1):109-11. PubMed ID: 2536252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of benzodiazepine treatment on cortical GABA(A) and muscarinic receptors: studies in schizophrenia and rats.
    McLeod MC; Scarr E; Dean B
    Psychiatry Res; 2010 Sep; 179(2):139-46. PubMed ID: 20483174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypoxia on muscarinic cholinergic and benzodiazepine/gamma-aminobutyric acid receptors in the rat brain.
    Ninomiya H; Taniguchi T; Fujiwara M
    Adv Exp Med Biol; 1988; 236():61-9. PubMed ID: 2853567
    [No Abstract]   [Full Text] [Related]  

  • 15. Demonstration of neurochemical tolerance following chronic barbital treatment.
    Lane SJ; Morgan WW
    Neurobehav Toxicol Teratol; 1985; 7(2):195-7. PubMed ID: 2987720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soman- or kainic acid-induced convulsions decrease muscarinic receptors but not benzodiazepine receptors.
    Churchill L; Pazdernik TL; Cross RS; Nelson SR; Samson FE
    Neurotoxicology; 1990; 11(1):57-71. PubMed ID: 2165227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]muscimol to calf cerebrocortical synaptic membranes and the effects of sulphur-containing convulsant and non-convulsant compounds.
    Egbuta JO; Griffiths R
    Neurochem Res; 1987 Jul; 12(7):589-95. PubMed ID: 3039390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine concentration in discrete brain areas following the withdrawal of barbital dependent rats.
    Morgan WW; Pfeil KA; Gonzales EG
    Life Sci; 1977 Feb; 20(3):493-9. PubMed ID: 557159
    [No Abstract]   [Full Text] [Related]  

  • 19. The binding of 3H-quinuclidinyl benzilate to cholinergic muscarinic receptors in rat brain region following chronic treatment with morphine and during abstinence.
    Das S; Matwyshyn GA; Bhargava HN
    Neuropeptides; 1984 Dec; 5(1-3):45-8. PubMed ID: 6543385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for GABA tolerance in barbiturate-dependent and withdrawn mice.
    Gray PL; Taberner PV
    Neuropharmacology; 1985 May; 24(5):437-44. PubMed ID: 2991801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.